[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572215":3},{"organization":4,"armGroups":7,"interventions":25,"overallOfficials":59,"centralContacts":63,"locations":70,"responsibleParty":299,"collaborators":11,"id":302,"slug":11,"hasResults":303,"nctId":304,"briefTitle":305,"officialTitle":306,"acronym":11,"eligibilityCriteria":307,"healthyVolunteers":303,"sex":308,"minAge":309,"maxAge":310,"enrollmentInfo":311,"targetDuration":11,"studyType":314,"phases":315,"briefSummary":317,"conditions":318,"keywords":11,"overallStatus":73,"whyStopped":11,"lastUpdateSubmitDate":322,"lastUpdatePostDateStruct":323,"startDateStruct":326,"completionDateStruct":328,"leadSponsor":330,"locationsCount":331},{"fullName":5,"class":6},"Qilu Hospital of Shandong University","OTHER",[8,16],{"label":9,"type":10,"description":11,"interventionNames":12},"Disitamab Vedotin+Sintilimab+S-1","EXPERIMENTAL",null,[13,14,15],"Drug: Disitamab Vedotin","Drug: Sintilimab","Drug: S-1",{"label":17,"type":18,"description":11,"interventionNames":19},"Trastuzumab+Chemotherapy（XELOX\u002FFP\u002FXP) ± Sintilimab","ACTIVE_COMPARATOR",[14,20,21,22,23,24],"Drug: Trastuzumab","Drug: Oxaliplatin","Drug: Capecitabine","Drug: 5-FU","Drug: Cisplatin",[26,31,35,39,43,47,51,55],{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":11},"DRUG","Disitamab Vedotin","2.5 mg\u002Fkg IV every 3 weeks",[9],{"type":27,"name":32,"description":33,"armGroupLabels":34,"otherNames":11},"Sintilimab","200 mg IV every 3 weeks",[9,17],{"type":27,"name":36,"description":37,"armGroupLabels":38,"otherNames":11},"S-1","40-60 mg BID for 14 days, every 3 weeks",[9],{"type":27,"name":40,"description":41,"armGroupLabels":42,"otherNames":11},"Trastuzumab","First load dose is 8.0mg\u002Fkg , then 6.0 mg\u002Fkg IV every 3 weeks",[17],{"type":27,"name":44,"description":45,"armGroupLabels":46,"otherNames":11},"Oxaliplatin","130 mg\u002Fm2 Q3W",[17],{"type":27,"name":48,"description":49,"armGroupLabels":50,"otherNames":11},"Capecitabine","1000 mg\u002Fm² Q3W",[17],{"type":27,"name":52,"description":53,"armGroupLabels":54,"otherNames":11},"5-FU","800 mg\u002Fm²",[17],{"type":27,"name":56,"description":57,"armGroupLabels":58,"otherNames":11},"Cisplatin","80 mg\u002Fm²",[17],[60],{"name":61,"affiliation":5,"role":62},"Lian Liu, MD","STUDY_CHAIR",[64,68],{"name":61,"role":65,"phone":66,"phoneExt":11,"email":67},"CONTACT","0531-82169851","tounao@126.com",{"name":69,"role":65,"phone":66,"phoneExt":11,"email":11},"Song Li, MD",[71,93,106,119,135,145,155,163,174,185,196,210,218,224,231,245,256,268,278,291],{"facility":72,"status":73,"city":74,"state":75,"zip":76,"country":77,"countryCode":78,"cosmosGeoPoint":79,"geoPoint":84,"contacts":85},"The First Affiliated Hospital of Zhengzhou University","RECRUITING","Zhengzhou","Henan","450052","China","CN",{"type":80,"coordinates":81},"Point",[82,83],113.64861,34.75778,{"lat":83,"lon":82},[86,90],{"name":87,"role":65,"phone":88,"phoneExt":11,"email":89},"Yongxu Jia, MD","+86 15237128281","jiayongxu111@126.com",{"name":91,"role":65,"phone":11,"phoneExt":11,"email":92},"Yanru Qin, MD","yanruqin@163.com",{"facility":94,"status":95,"city":96,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":98,"geoPoint":102,"contacts":103},"Binzhou Medical University Hospital","NOT_YET_RECRUITING","Binzhou","Shandong",{"type":80,"coordinates":99},[100,101],118.01667,37.36667,{"lat":101,"lon":100},[104],{"name":105,"role":65,"phone":11,"phoneExt":11,"email":11},"Feng Wang",{"facility":107,"status":73,"city":108,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Shengli Oilfield Central Hospital","Dongying",{"type":80,"coordinates":110},[111,112],118.49165,37.46271,{"lat":112,"lon":111},[115],{"name":116,"role":65,"phone":117,"phoneExt":11,"email":118},"Tingting Zhang, MD","18766757077","ztt850426@163.com",{"facility":120,"status":73,"city":121,"state":97,"zip":122,"country":77,"countryCode":78,"cosmosGeoPoint":123,"geoPoint":127,"contacts":128},"Shandong Provincial Hospital Affiliated to Shandong First Medical University","Jinan","250012",{"type":80,"coordinates":124},[125,126],116.99722,36.66833,{"lat":126,"lon":125},[129,133],{"name":130,"role":65,"phone":131,"phoneExt":11,"email":132},"Lei Cong, MD","15168889208","wdconglei@163.com",{"name":130,"role":134,"phone":11,"phoneExt":11,"email":11},"PRINCIPAL_INVESTIGATOR",{"facility":136,"status":73,"city":121,"state":97,"zip":122,"country":77,"countryCode":78,"cosmosGeoPoint":137,"geoPoint":139,"contacts":140},"Shandong Provincial Third Hospital",{"type":80,"coordinates":138},[125,126],{"lat":126,"lon":125},[141],{"name":142,"role":65,"phone":143,"phoneExt":11,"email":144},"Kainan Li, Doctor","15053125301","lkn_bean@163.com",{"facility":146,"status":73,"city":121,"state":97,"zip":122,"country":77,"countryCode":78,"cosmosGeoPoint":147,"geoPoint":149,"contacts":150},"Shandong Univerisity Qilu Hospital",{"type":80,"coordinates":148},[125,126],{"lat":126,"lon":125},[151],{"name":152,"role":65,"phone":153,"phoneExt":11,"email":154},"Lian Liu, MD, PhD","18560082903","lianliu@sdu.edu.cn",{"facility":156,"status":73,"city":121,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":157,"geoPoint":159,"contacts":160},"Jinan Third People's Hospital",{"type":80,"coordinates":158},[125,126],{"lat":126,"lon":125},[161],{"name":162,"role":65,"phone":11,"phoneExt":11,"email":11},"Zupeng Luan",{"facility":164,"status":73,"city":165,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"Affiliated Hospital of Jining Medical College","Jining",{"type":80,"coordinates":167},[168,169],116.58139,35.405,{"lat":169,"lon":168},[172],{"name":173,"role":65,"phone":11,"phoneExt":11,"email":11},"Junye Wang, MD",{"facility":175,"status":73,"city":176,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Liaocheng People's Hospital","Liaocheng",{"type":80,"coordinates":178},[179,180],116.00247,36.45064,{"lat":180,"lon":179},[183],{"name":184,"role":65,"phone":11,"phoneExt":11,"email":11},"Baozhong Wang",{"facility":186,"status":73,"city":187,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"Linyi Cancer Hospital","Linyi",{"type":80,"coordinates":189},[190,191],118.34278,35.06306,{"lat":191,"lon":190},[194],{"name":195,"role":65,"phone":11,"phoneExt":11,"email":11},"Zhen Li",{"facility":197,"status":73,"city":198,"state":97,"zip":199,"country":77,"countryCode":78,"cosmosGeoPoint":200,"geoPoint":204,"contacts":205},"Qilu Hospital of Shandong University(Qingdao)","Qingdao","250063",{"type":80,"coordinates":201},[202,203],120.38042,36.06488,{"lat":203,"lon":202},[206],{"name":207,"role":65,"phone":208,"phoneExt":11,"email":209},"Fangli Cao, MD","18561811170","qdsunying@foxmail.com",{"facility":211,"status":95,"city":198,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":212,"geoPoint":214,"contacts":215},"The Affiliated Hospital of Qingdao University",{"type":80,"coordinates":213},[202,203],{"lat":203,"lon":202},[216],{"name":217,"role":65,"phone":11,"phoneExt":11,"email":11},"Zimin Liu",{"facility":219,"status":95,"city":220,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":11,"geoPoint":11,"contacts":221},"Taian City Central Hospital","Taian",[222],{"name":223,"role":65,"phone":11,"phoneExt":11,"email":11},"Li Meng, MD",{"facility":225,"status":73,"city":220,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":11,"geoPoint":11,"contacts":226},"The Second Affiliated Hospital of Shandong First Medical University",[227],{"name":228,"role":65,"phone":229,"phoneExt":11,"email":230},"Haiyan Liu, MD","13001770627","Fylhy1998@163.com",{"facility":232,"status":73,"city":233,"state":97,"zip":234,"country":77,"countryCode":78,"cosmosGeoPoint":235,"geoPoint":239,"contacts":240},"Tengzhou Central People's Hospital","Tengzhou","277599",{"type":80,"coordinates":236},[237,238],117.19071,35.08357,{"lat":238,"lon":237},[241],{"name":242,"role":65,"phone":243,"phoneExt":11,"email":244},"Ling Li, MD","13863260929","lilingtz@163.com",{"facility":246,"status":95,"city":247,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":248,"geoPoint":252,"contacts":253},"Weifang Hospital of Traditional Chinese Medicine","Weifang",{"type":80,"coordinates":249},[250,251],119.10194,36.71,{"lat":251,"lon":250},[254],{"name":255,"role":65,"phone":11,"phoneExt":11,"email":11},"Zhonghai Du",{"facility":257,"status":73,"city":258,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":259,"geoPoint":263,"contacts":264},"Yantai Yuhuangding Hospital","Yantai",{"type":80,"coordinates":260},[261,262],121.44081,37.47649,{"lat":262,"lon":261},[265],{"name":266,"role":65,"phone":11,"phoneExt":11,"email":267},"Aina Liu","nana4312@sina.com",{"facility":269,"status":73,"city":258,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":270,"geoPoint":272,"contacts":273},"Yantaishan Hospital",{"type":80,"coordinates":271},[261,262],{"lat":262,"lon":261},[274],{"name":275,"role":65,"phone":276,"phoneExt":11,"email":277},"Dongmei Zhou, MD","13953590373","zhoudongmei68@163.com",{"facility":279,"status":73,"city":280,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":281,"geoPoint":285,"contacts":286},"Zibo Central Hospital","Zibo",{"type":80,"coordinates":282},[283,284],118.06333,36.79056,{"lat":284,"lon":283},[287],{"name":288,"role":65,"phone":289,"phoneExt":11,"email":290},"Yi Zhai, MD","18678186991","zhai-yi@21cn.com",{"facility":292,"status":73,"city":280,"state":97,"zip":11,"country":77,"countryCode":78,"cosmosGeoPoint":293,"geoPoint":295,"contacts":296},"Zibo First People's Hospital",{"type":80,"coordinates":294},[283,284],{"lat":284,"lon":283},[297],{"name":298,"role":65,"phone":11,"phoneExt":11,"email":11},"Fei Ding",{"type":134,"investigatorFullName":300,"investigatorTitle":301,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"Lian Liu, MD, PHD","Director","100572215",false,"NCT06730373","First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)","A Phase II, Open-Label, Multicenter Trial Comparing Disitamab Vedotin Plus Sintilimab and S-1 With Trastuzumab Plus Chemotherapy ± Sintilimab for First-Line Treatment of HER2-Positive Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (RCTS2)","Inclusion Criteria:\n\n1. Aged18-75 years, gender is not limited;\n2. Pathologically confirmed locally advanced gastric or gastroesophageal junction adenocarcinoma that is inoperable or has distant metastasis;\n3. HER2-Positive (IHC3+or IHC2+\u002FFISH+) ;\n4. Has at least 1 measurable lesion as determined by RECIST 1.1;\n5. There is no systematic treatment in the past, or the patient has received neoadjuvant\u002Fadjuvant chemotherapy, but the disease progresses or relapses more than 6 months after the end of treatment;\n6. Eastern Cooperative Oncology Group (ECOG) performance status of 0-1;\n7. Adequate organ function;\n8. The life expectancy is at least 3 months;\n\nExclusion Criteria:\n\n1. Allergy to any trial drug and its excipients, or serious allergy history, or contraindication of the trial drug;\n2. Cardiovascular and cerebrovascular events that are not well controlled;\n3. Has received systematic treatment with Chinese patent medicine or immunomodulatory drugs (including thymosin, interferon, interleukin, except for local use for ascites control) before the first administration within 2 weeks.\n4. Have a history of interstitial lung disease, non-infectious pneumonia, pulmonary fibrosis, acute lung disease, or systemic disease with poor control (including but not limited to diabetes, hypertension, etc.);\n5. Have a history of active immune deficiency or autoimmune diseases, including HIV positive test, or have other acquired or congenital immune deficiency diseases, or have a history of organ transplantation or autoimmune diseases;\n6. Severe chronic or active infection requires systemic antibacterial, antifungal or antiviral treatment, including tuberculosis infection.Have a history of active tuberculosis infection ≥ 1 year before recruitment should also be excluded, unless proved has been completed appropriate treatment;\n7. Brain metastasis or leptomeningeal metastasis;\n8. Clinically significant pleural effusion, pericardial effusion or ascites should be drained for many times within 2 weeks before the first administration of the trial drug;\n9. Has a second clinically detectable primary malignant tumor at the time of recruitment, or there were other malignant tumors in the past 5 years (except for fully treated skin basal cell carcinoma or cervical carcinoma in situ);\n10. Any major surgery was performed ≤ 28 days before the first trial drug administration;\n11. History of allogeneic stem cell transplantation or organ transplantation;","ALL","18 Years","75 Years",{"count":312,"type":313},110,"ESTIMATED","INTERVENTIONAL",[316],"PHASE2","This is a Phase II, randomized, multicenter, open-label clinical trial designed to compare Disitamab Vedotin plus Sintilimab and S-1 with Trastuzumab plus chemotherapy ± Sintilimab for first-line treatment of HER2-Positive advanced gastric or gastroesophageal junction adenocarcinoma.",[319,320,321],"HER2-positive Gastric Cancer","Metastatic Gastric Cancer","Unresectable Gastric Carcinoma","2024-12-29",{"date":324,"type":325},"2024-12-31","ACTUAL",{"date":327,"type":325},"2024-10-17",{"date":329,"type":313},"2027-12-31",{"name":5,"class":6},20]